InMed Pharmaceuticals, Inc. (INM)

1.77 +0.04 (+2.31%) USD  |  NASDAQ  |  May 22, 10:47
More

InMed Pharmaceuticals Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for INM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
CannaPharmaRx, Inc. Upgrade
Lexaria Bioscience Corp. Upgrade
Target Group, Inc. (Canada) Upgrade
Tilray Brands, Inc. Upgrade
NervGen Pharma Corp. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade